If any of these conditions are present, alternatives will be discussed, or the patient may not be cleared for GLP-1 treatment at all
"More studies are needed to help establish how effective these drugs are, what the long-term effects are, if some are better than others, and what dose is most effective for reducing drinking verus controlling blood glucose, for example," DiFeliceantonio said
Emerging evidence suggests that DPP-4 inhibitor use may be associated with an increased risk of bullous pemphigoid, an autoimmune blistering disorder characterized by edematous erythema and tense blisters [13, 31]
Non-cytotoxic concentrations impairs cell viability through oxidative DNA damage, GSH depletion, and stress-responsive genes (Hsp70 and Hsp90) induction (119)
R.WabaidurS
Of course any adverse event can be a flag, said another former FDA official who worked in the compounding division when the peptides were categorized as unsafe